As of the latest Form 4 filed Jun 26, 2026.
What Viemed Healthcare Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 62 most recent filings for VMD.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-26 | 2026-06-25 | Frazier William Chief Medical Officer | SSale | −10.0K | $11.72 | $117K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | Frazier William, Chief Medical Officer | MExercise | +10.0K | $1.81 | $18.1K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Smokoff Timothy Director | SSale | −5.00K | $11.41 | $57.0K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Smokoff Timothy, Director | SSale | −5.00K | $11.53 | $57.6K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Smokoff Timothy, Director | SSale | −5.00K | $11.56 | $57.8K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Smokoff Timothy, Director | SSale | −3.36K | $11.50 | $38.7K | No | Form 4 ↗ |
| 2026-06-26 | 2026-06-24 | Smokoff Timothy, Director | SSale | −1.64K | $11.48 | $18.8K | No | Form 4 ↗ |
| 2026-03-20 | 2026-03-20 | Moore Michael President | SSale | −65.0K | $8.77 | $570K | No | Form 4 ↗ |
| 2026-03-20 | 2026-03-19 | Moore Michael, President | SSale | −40.2K | $9.21 | $371K | No | Form 4 ↗ |
| 2026-03-20 | 2026-03-18 | Moore Michael, President | SSale | −31.6K | $9.42 | $297K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Trahan Jeremy General Counsel | DDisposition | −3.66K | $7.49 | $27.4K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Trahan Jeremy, General Counsel | MExercise | +3.66K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Trahan Jeremy, General Counsel | FTax | −4.78K | $7.49 | $35.8K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Trahan Jeremy, General Counsel | MExercise | +14.6K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Cambre Jerome Vice President of Sales | DDisposition | −2.93K | $7.49 | $21.9K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Cambre Jerome, Vice President of Sales | MExercise | +2.93K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Cambre Jerome, Vice President of Sales | FTax | −3.83K | $7.49 | $28.7K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Cambre Jerome, Vice President of Sales | MExercise | +11.7K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Frazier William Chief Medical Officer | DDisposition | −850.00 | $7.49 | $6.37K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Frazier William, Chief Medical Officer | MExercise | +850.00 | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Frazier William, Chief Medical Officer | FTax | −1.17K | $7.49 | $8.76K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Frazier William, Chief Medical Officer | MExercise | +3.40K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Fitzgerald Trae Chief Financial Officer | DDisposition | −3.33K | $7.49 | $24.9K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Fitzgerald Trae, Chief Financial Officer | MExercise | +3.33K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Fitzgerald Trae, Chief Financial Officer | FTax | −4.25K | $7.49 | $31.8K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Fitzgerald Trae, Chief Financial Officer | MExercise | +13.3K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Moore Michael President | DDisposition | −8.55K | $7.49 | $64.1K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Moore Michael, President | MExercise | +8.55K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Moore Michael, President | FTax | −9.36K | $7.49 | $70.1K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Moore Michael, President | MExercise | +34.2K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Hoyt Casey Chief Executive Officer | DDisposition | −12.4K | $7.49 | $92.9K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Hoyt Casey, Chief Executive Officer | MExercise | +12.4K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Hoyt Casey, Chief Executive Officer | FTax | −13.6K | $7.49 | $102K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | Hoyt Casey, Chief Executive Officer | MExercise | +49.6K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | ZEHNDER WILLIAM TODD Chief Operating Officer | DDisposition | −8.55K | $7.49 | $64.1K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | ZEHNDER WILLIAM TODD, Chief Operating Officer | MExercise | +8.55K | — | — | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | ZEHNDER WILLIAM TODD, Chief Operating Officer | FTax | −35.1K | $7.49 | $263K | No | Form 4 ↗ |
| 2026-01-23 | 2026-01-21 | ZEHNDER WILLIAM TODD, Chief Operating Officer | MExercise | +118K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Trahan Jeremy General Counsel | DDisposition | −1.22K | $7.33 | $8.95K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Trahan Jeremy, General Counsel | MExercise | +1.22K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Trahan Jeremy, General Counsel | FTax | −1.59K | $7.33 | $11.7K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Trahan Jeremy, General Counsel | MExercise | +4.88K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Cambre Jerome Vice President of Sales | DDisposition | −2.13K | $7.33 | $15.6K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Cambre Jerome, Vice President of Sales | MExercise | +2.13K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Cambre Jerome, Vice President of Sales | FTax | −2.78K | $7.33 | $20.4K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Cambre Jerome, Vice President of Sales | MExercise | +8.53K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Fitzgerald Trae Chief Financial Officer | DDisposition | −2.40K | $7.33 | $17.6K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Fitzgerald Trae, Chief Financial Officer | MExercise | +2.40K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Fitzgerald Trae, Chief Financial Officer | FTax | −3.13K | $7.33 | $23.0K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Fitzgerald Trae, Chief Financial Officer | MExercise | +9.59K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Moore Michael President | DDisposition | −6.74K | $7.33 | $49.4K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Moore Michael, President | MExercise | +6.74K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Moore Michael, President | FTax | −8.55K | $7.33 | $62.7K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Moore Michael, President | MExercise | +26.9K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Hoyt Casey Chief Executive Officer | DDisposition | −10.0K | $7.33 | $73.4K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Hoyt Casey, Chief Executive Officer | MExercise | +10.0K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Hoyt Casey, Chief Executive Officer | FTax | −12.1K | $7.33 | $88.8K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | Hoyt Casey, Chief Executive Officer | MExercise | +40.1K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | ZEHNDER WILLIAM TODD Chief Operating Officer | DDisposition | −6.74K | $7.33 | $49.4K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | ZEHNDER WILLIAM TODD, Chief Operating Officer | MExercise | +6.74K | — | — | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | ZEHNDER WILLIAM TODD, Chief Operating Officer | FTax | −8.55K | $7.33 | $62.7K | No | Form 4 ↗ |
| 2026-01-21 | 2026-01-17 | ZEHNDER WILLIAM TODD, Chief Operating Officer | MExercise | +26.9K | — | — | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also VMD’s full analysis or the market-wide insider trading feed. The tabs above jump to VMD’s other SEC data.
Source: SEC Form 4 filings for VMD, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.